Viewing Study NCT00466960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-12 @ 11:56 AM
Study NCT ID: NCT00466960
Status: COMPLETED
Last Update Posted: 2017-08-28
First Post: 2007-04-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Sponsor: University of Washington
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brenner Tumor View
None Fallopian Tube Cancer View
None Ovarian Clear Cell Cystadenocarcinoma View
None Ovarian Endometrioid Adenocarcinoma View
None Ovarian Mixed Epithelial Carcinoma View
None Ovarian Mucinous Cystadenocarcinoma View
None Ovarian Serous Cystadenocarcinoma View
None Ovarian Undifferentiated Adenocarcinoma View
None Peritoneal Cavity Cancer View
None Recurrent Ovarian Epithelial Cancer View
None Stage III Ovarian Epithelial Cancer View
None Stage IV Ovarian Epithelial Cancer View
Keywords: